N-terminal pro-brain natriuretic peptide and coronary artery disease

European Journal of Clinical Investigation

Volumn 37, Issue 1, 2007, Pages 1-7

  Karthikeyan, V J ^a   Lip, G Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER;

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; ATHEROSCLEROTIC PLAQUE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DISEASE MARKER; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; MORBIDITY; MORTALITY; NOTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; ST SEGMENT ELEVATION;

CORONARY ARTERIOSCLEROSIS; CROSS-SECTIONAL STUDIES; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 33845586005     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2007.01750.x     Document Type: Note

References (26)

1. Kragelund C, Gronning B, Kober L, Hildebrandt P, Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 2005;352:666-75.
2. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998;339:321-8.
3. Hall C. Essential biochemistry and physiology of (NT-pro) BNP. Eur J Heart Fail 2004;6:257-60.
4. Goetze JP, Christoffersen C, Perko M, Arendrup H, Rehfeld JF, Kastrup J. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J 2003;17:1105-7.
5. Kragelund C, Gronning B, Omland T, Kober L, Strande S, Steffensen R et al. Is N-terminal pro B-type natriuretic peptide (NT-proBNP) a useful screening test for angiographic findings in patients with stable coronary disease? Am Heart J 2006;151:712.
6. Ndrepepa G, Kastrati A, Braun S, Mehilli J, Niemoller K, von Beckerath N et al. N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease. Am J Med 2006;119:355.
7. Staub D, Jonas N, Zellweger MJ, Nusbaumer C, Wild D, Pfisterer ME et al. Use of N-terminal pro-B-type natriuretic peptide to detect myocardial ischemia. Am J Med 2005;118:1287.
8. Ndrepepa G, Braun S, Niemoller K, Mehilli J, von Beckerath N, von Beckerath O et al. Prognostic value of N-terminal pro-brain natriuretic peptide in patients with chronic stable angina. Circulation 2005;112:2102-7.
9. Weber M, Dill T, Arnold R, Rau M, Ekinci O, Muller KD et al. N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris. Am Heart J 2004;148:612-20.
10. Almeida R, Mariano L, Gavina C, Pinho T, Vasconcelos M, Ferreira A et al. The value of NT-proBNP in early risk stratification of acute coronary syndromes. Rev Port Cardio 2006;25:71-5.
11. Ezekowitz JA, Theroux P, Chang W, Mahaffey KW, Granger CB, Weaver WD et al. N-terminal pro-brain natriuretic peptide and the timing, extent and mortality in ST elevation myocardial infarction. Can J Cardiol 2006;22:393-7.
12. Bjorklund E, Jernberg T, Johanson P, Venge P, Dellborg M, Wallentin L et al. ASSENT-2 and ASSENT-PLUS Study Groups. Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction. Heart 2006;92:735-40.
13. Galvani M, Ottani F, Oltrona L, Ardissino D, Gensini GF, Maggioni AP et al. N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes. Circulation 2004;110:128-34.
14. James SK, Lindback J, Tilly J, Siegbahn A, Venge P, Armstrong P et al. Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV sub study. J Am Coll Cardiol 2006;48:1146-54.
15. Westerhout CM, Fu Y, Lauer MS, James S, Armstrong PW, Al-Hattab E et al. Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative STsegment depression and multiple biomarkers. J Am Coll Cardiol 2006;48:939-47.
16. Hong SN, Yoon NS, Ahn Y, Lim SY, Kim YS, Yun KH et al. N-terminal pro-B-type natriuretic peptide predicts significant coronary artery lesion in the unstable angina patients with normal electrocardiogram, echocardiogram, and cardiac enzymes. Circ J 2005;69:1472-6.
17. Lindahl B, Lindback J, Jernberg T, Johnston N, Stridsberg M, Venge P et al. Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC) -II sub study. J Am Coll Cardiol 2005;45:533-41.
18. Zeller M, Cottin Y, Laurent Y, Danchin N, L'Huillier I, Collin B et al. N-terminal pro-brain natriuretic peptide levels in patients with non-ST-elevation myocardial infarction. Cardiology 2004;102:37-40.
19. Bazzino O, Fuselli JJ, Botto F, Perez De Arenaza D, Bahit C, Dadone J for the PACS group of investigators. Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST-elevation acute coronary syndromes. Eur Heart J 2004;25:859-66.
20. Wolber T, Maeder M, Rickli H, Riesen W, Binggeli C, Dudr F et al. Use of N-terminal Pro-Brain Natriuretic Peptide for prediction of coronary artery stenosis. Eur J Clin Invest 2007; 37:18-25.
21. Chong AY, Blann AD, Patel J, Freestone B, Hughes E, Lip GY. Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide. Circulation 2004;110:1794-8.
22. Gardner RS, Ozalp F, Murday AJ, Robb SD, McDonagh TA. N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J 2003;24:1735-43.
23. Jernberg T, James S, Lindahl B, Johnston N, Stridsberg M, Venge P et al. Natriuretic peptides in unstable coronary artery disease. Eur Heart J 2004;25:1486-93.
24. Conen D, Pfisterer M, Martina B. Substantial intraindividual variability of BNP concentrations in patients with hypertension. J Hum Hypertens 2006;20:387-91.
25. Kanda H, Kita Y, Okamura T, Kadowaki T, Yoshida Y, Nakamura Y et al. What factors are associated with high plasma B-type natriuretic peptide levels in a general Japanese population? J Hum Hypertens 2005;19:165-72.
26. MacFadyen RJ. Intraindividual temporal variance of biomarkers and the definition of individualized prognosis in cardiovascular patients. J Hum Hypertens 2006;20:383-6.